These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14663355)

  • 1. Cytokeratin 7 immunoreactivity in rectal adenocarcinomas.
    Zhang PJ; Shah M; Spiegel GW; Brooks JJ
    Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):306-10. PubMed ID: 14663355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
    Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
    Tot T
    Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets.
    Tan J; Sidhu G; Greco MA; Ballard H; Wieczorek R
    Hum Pathol; 1998 Apr; 29(4):390-6. PubMed ID: 9563790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.
    Saad RS; Silverman JF; Khalifa MA; Rowsell C
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):196-201. PubMed ID: 19098678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of cytokeratin 7 and 20 for the diagnosis of cerebral metastases of adenocarcinoma: study of 78 cases].
    Fernandez C; Liprandi A; Bouvier-Labit C; Figarella-Branger D
    Ann Pathol; 2001 Apr; 21(2):129-35. PubMed ID: 11373582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
    Bayrak R; Yenidünya S; Haltas H
    Pathol Res Pract; 2011 Mar; 207(3):156-60. PubMed ID: 21282015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
    Su YC; Hsu YC; Chai CY
    Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine.
    Chen ZM; Wang HL
    Am J Surg Pathol; 2004 Oct; 28(10):1352-9. PubMed ID: 15371952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
    Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
    Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
    Ormsby AH; Haskell R; Jones D; Goldblum JR
    Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
    Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV
    Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis.
    Tot T; Samii S
    APMIS; 2003 Dec; 111(12):1075-82. PubMed ID: 14678015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
    Tsao SC; Su YC; Wang SL; Chai CY
    Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
    Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
    J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes.
    Choi HR; Sturgis EM; Rashid A; DeMonte F; Luna MA; Batsakis JG; El-Naggar AK
    Hum Pathol; 2003 Nov; 34(11):1101-7. PubMed ID: 14652810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.
    Tot T
    Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
    Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
    J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas.
    Loy TS; Calaluce RD
    Am J Clin Pathol; 1994 Dec; 102(6):764-7. PubMed ID: 7528468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.